Internal Medicine
Online ISSN : 1349-7235
Print ISSN : 0918-2918
ISSN-L : 0918-2918
Volume 48 , Issue 7
Showing 1-19 articles out of 19 articles from the selected issue
  • Eiji Oda, Ryu Kawai
    2009 Volume 48 Issue 7 Pages 497-502
    Published: 2009
    Released: April 01, 2009
    Background There have been conflicting data regarding the relationship between obesity and coronary heart disease (CHD) in Japan. Obesity was reported to be a risk factor of CHD in young and middle-aged males, but not in females or older males. The age- and gender-related differences in the correlations between obesity and obesity-related metabolic risk factors might contribute to these conflicting data.
    Methods Medical check-up data from 1,360 men and 821 women were divided into younger (= or < 51-year-old) and older (> 51-year-old) groups according to the median age and Spearman's correlation coefficients between waist circumference (WC) and obesity-related metabolic risk factors were calculated.
    Results The correlation coefficients between WC and triglyceride and between WC and high-sensitivity C-reactive protein (hs-CRP) were significantly stronger in younger men than in older men. There was no statistically significant difference in correlation coefficients between younger and older women. The correlation coefficients between WC and triglyceride, WC and HDL cholesterol, WC and hs-CRP, WC and gamma glutamyltransferase, and WC and alanine aminotransferase (ALT) were significantly stronger in younger men than in younger women. The correlation coefficient between WC and ALT was significantly stronger in older men than in older women. And the correlations between WC and SBP, WC and DBP, and WC and GGT tended to be stronger in younger men than in older men.
    Conclusion The correlations between abdominal obesity and obesity-related metabolic risk factors were stronger in younger men than in older men and women among Japanese.
    Download PDF (339K)
  • Yuzuru Inoue, Tomotaka Kawayama, Tomoaki Iwanaga, Hisamichi Aizawa
    2009 Volume 48 Issue 7 Pages 503-512
    Published: 2009
    Released: April 01, 2009
    Background Early diagnosis of chronic obstructive pulmonary disease (COPD) with latent pulmonary hypertension (PH) and cor pulmonale is important because the prognosis of this condition is poor.
    Objective To investigate the utility of brain natriuretic peptide (BNP) for prognostication of COPD, plasma BNP was measured in patients with COPD without symptoms or physical findings of PH or cor pulmonale.
    Methods Plasma BNP was measured in 60 patients with COPD, 10 asthmatics, and 30 healthy subjects. Echocardiography, arterial blood gas analysis, and spirometry were also performed. Mortality and exacerbation were compared between COPD patients with high and low plasma BNP levels over a 3-year follow-up period.
    Results Plasma BNP (mean ± SEM, pg/mL) in COPD patients (41.0±6.6) was significantly higher than in normal subjects (14.8±2.7) and asthmatics (17.4±4.5) (p<0.0001 and p<0.05, respectively). No significant correlations were observed between plasma BNP level and pulmonary function or hypoxia. There was, however, a significant correlation between plasma BNP level and % ejection fraction (r=-0.41, p=0.0197) and pulmonary artery systolic pressure (r=0.5, p=0.004). The period until initial COPD exacerbation in subjects with a high plasma BNP level was significantly shorter (p<0.05). Plasma BNP level during exacerbations (79.9±16.2) was also significantly higher than during stable disease (41.2±8.7) (p=0.004).
    Conclusion We suggest that plasma BNP is a non-invasive biomarker that can be used as a screening parameter for latent PH and left ventricular dysfunction, and also as a predictor of exacerbation in stable COPD.
    Download PDF (125K)
  • Reiko Toda, Tomoaki Hoshino, Tomotaka Kawayama, Haruki Imaoka, Yuki Sa ...
    2009 Volume 48 Issue 7 Pages 513-521
    Published: 2009
    Released: April 01, 2009
    Objective The concept of "lung age" is thought to be useful for understanding pulmonary function. In this study, we validated "lung age" to detect pulmonary function abnormalities in pulmonary diseases.
    Methods We used both spirometry and an electronic FEV1/FEV6 meter (FEV6 meter) to perform pulmonary function tests. We evaluated the sensitivity and specificity of FEV6 and FEV1/FEV6, and calculated "lung age" in Japanese subjects including those with chronic obstructive pulmonary disease (COPD), bronchial asthma (BA), and interstitial lung diseases (ILD).
    Results FEV1 (spirometer) vs. FEV1 (FEV6 meter), FVC (spirometer) vs. FEV6 (FEV6 meter), and FEV1/FVC (spirometer) vs. FEV1/FEV6 (FEV6 meter) measurements were all significantly and closely correlated. For the difference of "lung age" and "actual age", the area under the receiver operating characteristic curve (ROC-AUC) for detecting obstructive impairment was 0.807 (spirometer) and 0.772 (FEV6 meter), respectively. The corresponding ROC-AUC for detecting restrictive impairment was 0.891 and 0.836, respectively, and that for detecting both obstructive and restrictive impairment was 0.918 and 0.853, respectively. For detection of both obstructive and restrictive impairment, the difference of the "lung age" and "actual age" cut-off value, corresponding to the greatest sum of sensitivity and specificity, was 18.3 years (spirometer) and 19.8 years (FEV6 meter), respectively. The sensitivity was 0.783 (spirometer) and 0.801 (FEV6 meter), and the specificity was 0.895 (spirometer) and 0.790 (FEV6 meter), respectively.
    Conclusion "Lung age" can provide an easy interpretation of the results, and can detect pulmonary function abnormalities in pulmonary diseases.
    Download PDF (276K)
  • Timuçin Kasifoglu, Döndü Üsküdar Cansu, Cen ...
    2009 Volume 48 Issue 7 Pages 523-526
    Published: 2009
    Released: April 01, 2009
    Objective Familial Mediterranean fever (FMF) is characterized by recurrent episodes of peritonitis. Abdominal FMF attacks can be indistinguishable from those of an acute abdominal emergency, and patients may undergo one or more laparotomies before the true nature of their disease is documented. The objectives of this study were to investigate the frequency and reasons for abdominal surgeries performed on patients with FMF.
    Methods We retrospectively reviewed the files of 254 patients with FMF (127 males, 127 females, mean age 27.2±6.3 years). We also included 182 healthy individuals for this study (89 males, 93 females, mean age 27.6±5 years; range 11-43) to make a comparison between FMF and healthy controls (HC) with respect to frequency of abdominal operations.
    Results The number of patients with abdominal surgery in FMF group was 74 (29.1%). The number of surgeries performed in 74 patients with FMF was 92. The first abdominal surgery before the diagnosis of FMF was appendectomy in 68 patients (26.6%). In HC group, the number of abdominal operations was found to be 16 (8.7%). Of these abdominal operations, 9 (4.9%) were due to appendectomy. The rate of total abdominal operations and appendectomy were significantly higher in FMF group than in HC group (p=0.0001).
    Conclusion Abdominal attacks of FMF patients may cause an unnecessary laparotomy prior to the diagnosis of FMF. FMF patients can present with abdominal emergency while they are receiving colchicine. Therefore, each abdominal pain should be carefully determined according to clinical findings. The purpose of this study was to emphasize the misdiagnosis of appendicitis.
    Download PDF (421K)
  • Katsunori Yanagihara, Koichi Izumikawa, Futoshi Higa, Masao Tateyama, ...
    2009 Volume 48 Issue 7 Pages 527-535
    Published: 2009
    Released: April 01, 2009
    Background and Objective The growing problem of drug resistance among respiratory pathogens in community-acquired pneumonia (CAP), particularly Streptococcus pneumoniae, (S. pneumoniae) has complicated initial empiric therapy of CAP. This study was undertaken to evaluate the efficacy and tolerability of a 3-day course of azithromycin in adults with mild to moderately severe CAP, and to determine whether in vitro macrolide resistance among strains of S. pneumoniae is related to clinical efficacy/failure.
    Methods An open-label, non-comparative study was undertaken at 3 university-affiliated hospitals in Japan. Patients were eligible if they were 18 years or older and had mild or moderately severe CAP. All patients received azithromycin 500 mg/day for three days, and clinical and microbiological responses were evaluated 1 and 2 weeks after initiating therapy.
    Results A total of 78 patients received the study medication, 59 of whom had sufficient data available for efficacy analysis. Overall, a good clinical response with azithromycin was achieved in 49 patients (83.1%) and a microbiological response was achieved in 78.3%. Azithromycin resistance, based on CLSI criteria, was demonstrated in 85.7% (12/14) of S. pneumoniae isolates, and the presence of ermB genes was found in 50.0% (7/14). However, among patients in whom S. pneumoniae was isolated (n=17), a good clinical response was achieved in 76.5% (13/17), and the microbiological response rate was 64.3% (9/14). Furthermore, 6 of 7 patients in whom high-level resistance was documented (MICs >256 μg/mL and carrying ermB genes) exhibited good clinical responses. Azithromycin was well tolerated; adverse events, mainly of a gastrointestinal nature, were recorded in 6 patients (7.7%).
    Conclusion Most patients responed well to azithromycin, indicating that azithromycin might be clinically effective for the treatment of CAP with macrolide-resistant S. pneumoniae. However, a larger study is necessary to prove the efficacy against macrolide-resistant S. pneumoniae.
    Download PDF (324K)
  • Yasuharu Tokuda, Masahiro Koizumi, Gerald H. Stein, Richard B. Birrer
    2009 Volume 48 Issue 7 Pages 537-543
    Published: 2009
    Released: April 01, 2009
    Objective To derive and validate a clinical prediction model with high sensitivity for differentiating aseptic meningitis (AM) patients from bacterial meningitis (BM) patients.
    Methods We developed the model using the derivation cohort in a community rural hospital in Okinawa and assessed its performance using the validation cohort in a metropolitan urban hospital in Tokyo. There were 66 (39.5%) and 5 (17.9%) adult patients with BM among the derivation (n=167) and the validation cohort (n=28), respectively. Recursive partitioning analysis was used to determine the important classification variables and to develop a sensitive model to safely exclude BM.
    Results The model produced high- and low-risk groups based on the following: 1) Gram stain, 2) CSF neutrophil percent ≤15%, 3) CSF neutrophil count ≤150 cells/mm3, and, 4) mental status change. Among the derivation cohort, there were 65 patients with BM in the high-risk group (n=76), while only one patient with BM was noted (sensitivity, 99%) in the low-risk group (n=91). Among the validation cohort, there were 5 patients with BM in the high-risk group (n=7), while no patient was classified with BM (sensitivity, 100%) in the low-risk group (n=21).
    Conclusion This simple and sensitive model might be useful to safely identify low-risk patients for BM who would not require antibiotic treatment.
    Download PDF (116K)